The DOI matches its Crossref record; 262 of the 262 references it cites were found in a registry or an index.
The Unique Molecular and Cellular Microenvironment of Ovarian Cancer
Open accessAbstract
The reciprocal interplay of cancer cells and host cells is an indispensable prerequisite for tumor growth and progression. Cells of both the innate and adaptive immune system, in particular tumor-associated macrophages (TAMs) and T cells, as well as cancer-associated fibroblasts enter into a malicious liaison with tumor cells to create a tumor-promoting and immunosuppressive tumor microenvironment (TME). Ovarian cancer, the most lethal of all gynecological malignancies, is characterized by a unique TME that enables specific and efficient metastatic routes, impairs immune surveillance, and mediates therapy resistance. A characteristic feature of the ovarian cancer TME is the role of resident host cells, in particular activated mesothelial cells, which line the peritoneal cavity in huge numbers, as well as adipocytes of the omentum, the preferred site of metastatic lesions. Another crucial factor is the peritoneal fluid, which enables the transcoelomic spread of tumor cells to other pelvic and peritoneal organs, and occurs at more advanced stages as a malignancy-associated effusion. This ascites is rich in tumor-promoting soluble factors, extracellular vesicles and detached cancer cells as well as large numbers of T cells, TAMs, and other host cells, which cooperate with resident host cells to support tumor progression and immune evasion. In this review, we summarize and discuss our current knowledge of the cellular and molecular interactions that govern this interplay with a focus on signaling networks formed by cytokines, lipids, and extracellular vesicles; the pathophysiologial roles of TAMs and T cells; the mechanism of transcoelomic metastasis; and the cell type selective processing of signals from the TME.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
Integrated genomic analyses of ovarian carcinoma
Perou, C. M. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/hvp3-wg08 · Cited by 7,925
MANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528
Curiel, T. J., Coukos, G., Zou, L., Alvarez, X., Cheng, P., Mottram, P., Evdemon-Hogan, M., Conejo-Garcia, J. R., Zhang, L., Burow, M., et al. (2004) · Nature Medicine · doi:10.1038/nm1093 · Cited by 5,151
Macrophage biology in development, homeostasis and disease
Wynn, T. A., Chawla, A., & Pollard, J. W. (2013) · Nature · doi:10.1038/nature12034 · Cited by 4,684
Molecular and cellular insights into T cell exhaustion
Wherry, E. J., & Kurachi, M. (2015) · Nature Reviews Immunology · doi:10.1038/nri3862 · Cited by 4,652
Tumors: Wounds That Do Not Heal
Flier, J. S., Underhill, L. H., & Dvorak, H. F. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612253152606 · Cited by 4,391 · cited 2×
“Moreover, type I, III, and V collagens are major components of the TME, similar to a healing wound (233).”
BackgroundSTATs in cancer inflammation and immunity: a leading role for STAT3
Yu, H., Pardoll, D., & Jove, R. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2734 · Cited by 4,383
Tumor-Associated Macrophages: From Mechanisms to Therapy
Noy, R., & Pollard, J. W. (2014) · Immunity · doi:10.1016/j.immuni.2014.06.010 · Cited by 4,089
Coordinated regulation of myeloid cells by tumours
Gabrilovich, D. I., Ostrand-Rosenberg, S., & Bronte, V. (2012) · Nature Reviews Immunology · doi:10.1038/nri3175 · Cited by 3,544
Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer
Zhang, L., Conejo-Garcia, J. R., Katsaros, D., Gimotty, P. A., Massobrio, M., Regnani, G., Makrigiannakis, A., Gray, H., Schlienger, K., Liebman, M. N., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020177 · Cited by 3,397
Tumour-educated macrophages promote tumour progression and metastasis
Pollard, J. W. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1256 · Cited by 3,367
Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
Chang, C.-H., Qiu, J., O’Sullivan, D., Buck, M. D., Noguchi, T., Curtis, J. D., Chen, Q., Gindin, M., Gubin, M. M., van der Windt, G. J. W., et al. (2015) · Cell · doi:10.1016/j.cell.2015.08.016 · Cited by 3,331
The prognostic landscape of genes and infiltrating immune cells across human cancers
Gentles, A. J., Newman, A. M., Liu, C. L., Bratman, S. V., Feng, W., Kim, D., Nair, V. S., Xu, Y., Khuong, A., Hoang, C. D., et al. (2015) · Nature Medicine · doi:10.1038/nm.3909 · Cited by 3,118
Molecular mechanisms of T cell co-stimulation and co-inhibition
Chen, L., & Flies, D. B. (2013) · Nature Reviews Immunology · doi:10.1038/nri3405 · Cited by 3,114
A Lineage of Myeloid Cells Independent of Myb and Hematopoietic Stem Cells
Schulz, C., Perdiguero, E. G., Chorro, L., Szabo-Rogers, H., Cagnard, N., Kierdorf, K., Prinz, M., Wu, B., Jacobsen, S. E. W., Pollard, J. W., et al. (2012) · Science · doi:10.1126/science.1219179 · Cited by 2,578
Sato, E., Olson, S. H., Ahn, J., Bundy, B., Nishikawa, H., Qian, F., Jungbluth, A. A., Frosina, D., Gnjatic, S., Ambrosone, C., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509182102 · Cited by 2,372
Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth
Nieman, K. M., Kenny, H. A., Penicka, C. V., Ladanyi, A., Buell-Gutbrod, R., Zillhardt, M. R., Romero, I. L., Carey, M. S., Mills, G. B., Hotamisligil, G. S., et al. (2011) · Nature Medicine · doi:10.1038/nm.2492 · Cited by 2,279
Regulation of immune responses by extracellular vesicles
Robbins, P. D., & Morelli, A. E. (2014) · Nature Reviews Immunology · doi:10.1038/nri3622 · Cited by 2,260
Revisiting STAT3 signalling in cancer: new and unexpected biological functions
Yu, H., Lee, H., Herrmann, A., Buettner, R., & Jove, R. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3818 · Cited by 2,137
Davies, L. C., Jenkins, S. J., Allen, J. E., & Taylor, P. R. (2013) · Nature Immunology · doi:10.1038/ni.2705 · Cited by 2,096
Regulatory T cells in cancer immunotherapy
Tanaka, A., & Sakaguchi, S. (2017) · Cell Research · doi:10.1038/cr.2016.151 · Cited by 1,860
Immunosuppressive effects of apoptotic cells
Voll, R. E., Herrmann, M., Roth, E. A., Stach, C., Kalden, J. R., & Girkontaite, I. (1997) · Nature · doi:10.1038/37022 · Cited by 1,787
Ovarian Cancer Development and Metastasis
Lengyel, E. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.100105 · Cited by 1,672
CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans
Beatty, G. L., Chiorean, E. G., Fishman, M. P., Saboury, B., Teitelbaum, U. R., Sun, W., Huhn, R. D., Song, W., Li, D., Sharp, L. L., et al. (2011) · Science · doi:10.1126/science.1198443 · Cited by 1,672
Transcriptional control of effector and memory CD8+ T cell differentiation
Kaech, S. M., & Cui, W. (2012) · Nature Reviews Immunology · doi:10.1038/nri3307 · Cited by 1,628
The JAK-STAT Pathway: Impact on Human Disease and Therapeutic Intervention
O'Shea, J. J., Schwartz, D. M., Villarino, A. V., Gadina, M., McInnes, I. B., & Laurence, A. (2015) · Annual Review of Medicine · doi:10.1146/annurev-med-051113-024537 · Cited by 1,599
Whole–genome characterization of chemoresistant ovarian cancer
Patch, A.-M., Christie, E. L., Etemadmoghadam, D., Garsed, D. W., George, J., Fereday, S., Nones, K., Cowin, P., Alsop, K., Bailey, P. J., et al. (2015) · Nature · doi:10.1038/nature14410 · Cited by 1,569
NF‐κB and the link between inflammation and cancer
DiDonato, J. A., Mercurio, F., & Karin, M. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01099.x · Cited by 1,482
Regulation of Immune Responses by Prostaglandin E2
Kalinski, P. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1101029 · Cited by 1,474
Simpson, T. R., Li, F., Montalvo-Ortiz, W., Sepulveda, M. A., Bergerhoff, K., Arce, F., Roddie, C., Henry, J. Y., Yagita, H., Wolchok, J. D., et al. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20130579 · Cited by 1,472
Demonstration of an interferon γ-dependent tumor surveillance system in immunocompetent mice
Kaplan, D. H., Shankaran, V., Dighe, A. S., Stockert, E., Aguet, M., Old, L. J., & Schreiber, R. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7556 · Cited by 1,465
Rethinking ovarian cancer: recommendations for improving outcomes
Vaughan, S., Coward, J. I., Bast, R. C., Berchuck, A., Berek, J. S., Brenton, J. D., Coukos, G., Crum, C. C., Drapkin, R., Etemadmoghadam, D., et al. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3144 · Cited by 1,464
Phosphoenolpyruvate Is a Metabolic Checkpoint of Anti-tumor T Cell Responses
Ho, P.-C., Bihuniak, J. D., Macintyre, A. N., Staron, M., Liu, X., Amezquita, R., Tsui, Y.-C., Cui, G., Micevic, G., Perales, J. C., et al. (2015) · Cell · doi:10.1016/j.cell.2015.08.012 · Cited by 1,462
The cellular and molecular origin of tumor-associated macrophages
Franklin, R. A., Liao, W., Sarkar, A., Kim, M. V., Bivona, M. R., Liu, K., Pamer, E. G., & Li, M. O. (2014) · Science · doi:10.1126/science.1252510 · Cited by 1,393
Combination cancer immunotherapy and new immunomodulatory targets
Mahoney, K. M., Rennert, P. D., & Freeman, G. J. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4591 · Cited by 1,294
Identification and Characterization of Ovarian Cancer-Initiating Cells from Primary Human Tumors
Zhang, S., Balch, C., Chan, M. W., Lai, H.-C., Matei, D., Schilder, J. M., Yan, P. S., Huang, T. H.-M., & Nephew, K. P. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0364 · Cited by 1,293
Wymann, M. P., & Schneiter, R. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2335 · Cited by 1,291
Escudier, B., Dorval, T., Chaput, N., André, F., Caby, M.-P., Novault, S., Flament, C., Leboulaire, C., Borg, C., Amigorena, S., et al. (2005) · Journal of Translational Medicine · doi:10.1186/1479-5876-3-10 · Cited by 1,280
Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy
Peng, D., Kryczek, I., Nagarsheth, N., Zhao, L., Wei, S., Wang, W., Sun, Y., Zhao, E., Vatan, L., Szeliga, W., et al. (2015) · Nature · doi:10.1038/nature15520 · Cited by 1,201
Hamanishi, J., Mandai, M., Ikeda, T., Minami, M., Kawaguchi, A., Murayama, T., Kanai, M., Mori, Y., Matsumoto, S., Chikuma, S., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.62.3397 · Cited by 1,180
Molecular recognition of fatty acids by peroxisome proliferator-activated receptors
Xu, H. E., Lambert, M. H., Montana, V. G., Parks, D. J., Blanchard, S. G., Brown, P. J., Sternbach, D. D., Lehmann, J. M., Wisely, G. B., Willson, T. M., et al. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80467-0 · Cited by 1,169
NK cells and cancer: you can teach innate cells new tricks
Morvan, M. G., & Lanier, L. L. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2015.5 · Cited by 1,162
Dangerous liaisons: STAT3 and NF-κB collaboration and crosstalk in cancer
Grivennikov, S. I., & Karin, M. (2010) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2009.11.005 · Cited by 1,160
A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer
Morse, M. A., Garst, J., Osada, T., Khan, S., Hobeika, A., Clay, T. M., Valente, N., Shreeniwas, R., Sutton, M. A., Delcayre, A., et al. (2005) · Journal of Translational Medicine · doi:10.1186/1479-5876-3-9 · Cited by 1,120
Woo, E. Y., Chu, C., Goletz, T. J., Schlienger, K., Yeh, H., Coukos, G., Rubin, S. C., Kaiser, L. R., & June, C. H. (2001) · PubMed · Cited by 1,108
Ledermann, J. A., Raja, F. A., Fotopoulou, C., Gonzalez-Martin, A., Colombo, N., & Sessa, C. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt333 · Cited by 1,104
The emerging role of lysophosphatidic acid in cancer
Mills, G. B., & Moolenaar, W. H. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1143 · Cited by 1,094
The role of IL-6 and STAT3 in inflammation and cancer
Hodge, D. R., Hurt, E. M., & Farrar, W. L. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.08.016 · Cited by 950
Glinsky, G. V., Berezovska, O., & Glinskii, A. B. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23412 · Cited by 916
Circuitry of nuclear factor κB signaling
Hoffmann, A., & Baltimore, D. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00375.x · Cited by 907
Matsuzaki, J., Gnjatic, S., Mhawech-Fauceglia, P., Beck, A., Miller, A., Tsuji, T., Eppolito, C., Qian, F., Lele, S., Shrikant, P., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1003345107 · Cited by 859
Selby, M. J., Engelhardt, J. J., Quigley, M., Henning, K. A., Chen, T., Srinivasan, M., & Korman, A. J. (2013) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-13-0013 · Cited by 857
Au Yeung, C. L., Co, N.-N., Tsuruga, T., Yeung, T.-L., Kwan, S.-Y., Leung, C. S., Li, Y., Lu, E. S., Kwan, K., Wong, K.-K., et al. (2016) · Nature Communications · doi:10.1038/ncomms11150 · Cited by 774
Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC
Besse, B., Charrier, M., Lapierre, V., Dansin, E., Lantz, O., Planchard, D., Le Chevalier, T., Livartoski, A., Barlesi, F., Laplanche, A., et al. (2016) · OncoImmunology · doi:10.1080/2162402x.2015.1071008 · Cited by 749
Self-citationMetalloproteinases and their inhibitors: Regulators of wound healing
Gill, S. E., & Parks, W. C. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.10.024 · Cited by 742
Birge, R. B., Boeltz, S., Kumar, S., Carlson, J., Wanderley, J., Calianese, D., Barcinski, M., Brekken, R. A., Huang, X., Hutchins, J. T., et al. (2016) · Cell Death & Differentiation · doi:10.1038/cdd.2016.11 · Cited by 725
Two physically, functionally, and developmentally distinct peritoneal macrophage subsets
Ghosn, E. E. B., Cassado, A. A., Govoni, G. R., Fukuhara, T., Yang, Y., Monack, D. M., Bortoluci, K. R., Almeida, S. R., Herzenberg, L. A., & Herzenberg, L. A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0915000107 · Cited by 689
Ionic immune suppression within the tumour microenvironment limits T cell effector function
Eil, R., Vodnala, S. K., Clever, D., Klebanoff, C. A., Sukumar, M., Pan, J. H., Palmer, D. C., Gros, A., Yamamoto, T. N., Patel, S. J., et al. (2016) · Nature · doi:10.1038/nature19364 · Cited by 678
Dighe, A. S., Richards, E., Old, L. J., & Schreiber, R. D. (1994) · Immunity · doi:10.1016/1074-7613(94)90087-6 · Cited by 663
Prognostic significance of tumor-infiltrating T cells in ovarian cancer: A meta-analysis
Hwang, W.-T., Adams, S. F., Tahirovic, E., Hagemann, I. S., & Coukos, G. (2012) · Gynecologic Oncology · doi:10.1016/j.ygyno.2011.09.039 · Cited by 661
The R-spondin/Lgr5/Rnf43 module: regulator of Wnt signal strength
de Lau, W., Peng, W. C., Gros, P., & Clevers, H. (2014) · Genes & Development · doi:10.1101/gad.235473.113 · Cited by 656
Hodi, F. S., Butler, M., Oble, D. A., Seiden, M. V., Haluska, F. G., Kruse, A., MacRae, S., Nelson, M., Canning, C., Lowy, I., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712237105 · Cited by 650
Lysophosphatidic Acid as a Potential Biomarker for Ovarian and Other Gynecologic Cancers
Xu, Y. (1998) · JAMA · doi:10.1001/jama.280.8.719 · Cited by 637
Clinical blockade of PD1 and LAG3 — potential mechanisms of action
Nguyen, L. T., & Ohashi, P. S. (2015) · Nature Reviews Immunology · doi:10.1038/nri3790 · Cited by 627
Shaping Gene Expression in Activated and Resting Primary Macrophages by IL-10
Lang, R., Patel, D., Morris, J. J., Rutschman, R. L., & Murray, P. J. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.5.2253 · Cited by 613
Perets, R., Wyant, G. A., Muto, K. W., Bijron, J. G., Poole, B. B., Chin, K. T., Chen, J. Y. H., Ohman, A. W., Stepule, C. D., Kwak, S., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.10.013 · Cited by 596
Tumors: Wounds That Do Not Heal—Redux
Dvorak, H. F. (2015) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-14-0209 · Cited by 592
Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research
Kipps, E., Tan, D. S. P., & Kaye, S. B. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3432 · Cited by 562
Regulation of Tumor Metastasis by Myeloid-Derived Suppressor Cells
Condamine, T., Ramachandran, I., Youn, J.-I., & Gabrilovich, D. I. (2015) · Annual Review of Medicine · doi:10.1146/annurev-med-051013-052304 · Cited by 521
Significance of CD44 and CD24 as Cancer Stem Cell Markers: An Enduring Ambiguity
Jaggupilli, A., & Elkord, E. (2012) · Clinical and Developmental Immunology · doi:10.1155/2012/708036 · Cited by 510
Duluc, D., Delneste, Y., Tan, F., Moles, M.-P., Grimaud, L., Lenoir, J., Preisser, L., Anegon, I., Catala, L., Ifrah, N., et al. (2007) · Blood · doi:10.1182/blood-2007-02-072587 · Cited by 491
The Next Hurdle in Cancer Immunotherapy: Overcoming the Non–T-Cell–Inflamed Tumor Microenvironment
Gajewski, T. F. (2015) · Seminars in Oncology · doi:10.1053/j.seminoncol.2015.05.011 · Cited by 488
Ahmed, N., & Stenvers, K. L. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00256 · Cited by 482
Obermajer, N., Muthuswamy, R., Odunsi, K., Edwards, R. P., & Kalinski, P. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-2449 · Cited by 464
Saccani, A., Schioppa, T., Porta, C., Biswas, S. K., Nebuloni, M., Vago, L., Bottazzi, B., Colombo, M. P., Mantovani, A., & Sica, A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1867 · Cited by 455
Bulliard, Y., Jolicoeur, R., Windman, M., Rue, S. M., Ettenberg, S., Knee, D. A., Wilson, N. S., Dranoff, G., & Brogdon, J. L. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20130573 · Cited by 446
Tumor-associated macrophages: unwitting accomplices in breast cancer malignancy
Williams, C. B., Yeh, E. S., & Soloff, A. C. (2016) · npj Breast Cancer · doi:10.1038/npjbcancer.2015.25 · Cited by 444
Macrophages Induce Invasiveness of Epithelial Cancer Cells Via NF-κB and JNK
Hagemann, T., Wilson, J., Kulbe, H., Li, N. F., Leinster, D. A., Charles, K., Klemm, F., Pukrop, T., Binder, C., & Balkwill, F. R. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.2.1197 · Cited by 434
Webb, J. R., Milne, K., Watson, P., deLeeuw, R. J., & Nelson, B. H. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1877 · Cited by 434
Ramirez-Carrozzi, V. R., Nazarian, A. A., Li, C. C., Gore, S. L., Sridharan, R., Imbalzano, A. N., & Smale, S. T. (2006) · Genes & Development · doi:10.1101/gad.1383206 · Cited by 422
Effector T Cells Abrogate Stroma-Mediated Chemoresistance in Ovarian Cancer
Wang, W., Kryczek, I., Dostál, L., Lin, H., Tan, L., Zhao, L., Lu, F., Wei, S., Maj, T., Peng, D., et al. (2016) · Cell · doi:10.1016/j.cell.2016.04.009 · Cited by 422
IL-12 secreting tumor-targeted chimeric antigen receptor T cells eradicate ovarian tumors in vivo
Koneru, M., Purdon, T. J., Spriggs, D., Koneru, S., & Brentjens, R. J. (2015) · OncoImmunology · doi:10.4161/2162402x.2014.994446 · Cited by 418
Ovarian Cancer Cells Polarize Macrophages Toward A Tumor-Associated Phenotype
Hagemann, T., Wilson, J., Burke, F., Kulbe, H., Li, N. F., Plüddemann, A., Charles, K., Gordon, S., & Balkwill, F. R. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.8.5023 · Cited by 411
Malignant ascites-derived exosomes of ovarian carcinoma patients contain CD24 and EpCAM
Runz, S., Keller, S., Rupp, C., Stoeck, A., Issa, Y., Koensgen, D., Mustea, A., Sehouli, J., Kristiansen, G., & Altevogt, P. (2007) · Gynecologic Oncology · doi:10.1016/j.ygyno.2007.08.064 · Cited by 399
Prognostic and Therapeutic Relevance of Molecular Subtypes in High-Grade Serous Ovarian Cancer
Konecny, G. E., Wang, C., Hamidi, H., Winterhoff, B., Kalli, K. R., Dering, J., Ginther, C., Chen, H.-W., Dowdy, S., Cliby, W., et al. (2014) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dju249 · Cited by 398
Murray, P. J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500419102 · Cited by 394
Tumour-derived exosomes and their role in cancer-associated T-cell signalling defects
Taylor, D. D., & Gerçel-Taylor, C. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602316 · Cited by 391
Junge, H. J., Yang, S., Burton, J. B., Paes, K., Shu, X., French, D. M., Costa, M., Rice, D. S., & Ye, W. (2009) · Cell · doi:10.1016/j.cell.2009.07.048 · Cited by 390
Development of Foxp3+ Regulatory T Cells Is Driven by the c-Rel Enhanceosome
Ruan, Q., Kameswaran, V., Tone, Y., Li, L., Liou, H.-C., Greene, M. I., Tone, M., & Chen, Y. H. (2009) · Immunity · doi:10.1016/j.immuni.2009.10.006 · Cited by 378
TLR signaling by tumor and immune cells: a double-edged sword
Huang, B., Zhao, J., Unkeless, J. C., Feng, Z. H., & Xiong, H. (2008) · Oncogene · doi:10.1038/sj.onc.1210904 · Cited by 377
The Transcription Factor Gata6 Links Tissue Macrophage Phenotype and Proliferative Renewal
Rosas, M., Davies, L. C., Giles, P. J., Liao, C.-T., Kharfan, B., Stone, T. C., O’Donnell, V. B., Fraser, D. J., Jones, S. A., & Taylor, P. R. (2014) · Science · doi:10.1126/science.1251414 · Cited by 377
Kenny, H. A., Kaur, S., Coussens, L. M., & Lengyel, E. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33775 · Cited by 370
Liao, J., Qian, F., Tchabo, N., Mhawech-Fauceglia, P., Beck, A., Qian, Z., Wang, X., Huss, W. J., Lele, S. B., Morrison, C. D., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0084941 · Cited by 364
Yamamoto, S., Konishi, I., Mandai, M., Kuroda, H., Komatsu, T., Nanbu, K., Sakahara, H., & Mori, T. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.537 · Cited by 356
Loss of E-Cadherin Promotes Ovarian Cancer Metastasis via α5-Integrin, which Is a Therapeutic Target
Sawada, K., Mitra, A. K., Radjabi, A. R., Bhaskar, V., Kistner, E. O., Tretiakova, M., Jagadeeswaran, S., Montag, A., Becker, A., Kenny, H. A., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5167 · Cited by 356
Ovarian surface epithelium at the junction area contains a cancer-prone stem cell niche
Flesken-Nikitin, A., Hwang, C.-I., Cheng, C.-Y., Michurina, T. V., Enikolopov, G., & Nikitin, A. Y. (2013) · Nature · doi:10.1038/nature11979 · Cited by 347
Dijkgraaf, E. M., Heusinkveld, M., Tummers, B., Vogelpoel, L. T. C., Goedemans, R., Jha, V., Nortier, J. W. R., Welters, M. J. P., Kroep, J. R., & van der Burg, S. H. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3542 · Cited by 346
Regulatory T cells in nonlymphoid tissues
Burzyn, D., Benoist, C., & Mathis, D. (2013) · Nature Immunology · doi:10.1038/ni.2683 · Cited by 342
Negus, R. P. M., Stamp, G. W. H., Hadley, J., & Balkwill, F. R. (1997) · Europe PMC (PubMed Central) · Cited by 339
Lysophospholipids Are Potential Biomarkers of Ovarian Cancer
Sutphen, R., Xu, Y., Wilbanks, G. D., Fiorica, J., Grendys, E. C., LaPolla, J. P., Arango, H., Hoffman, M. S., Martino, M., Wakeley, K., et al. (2004) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.1185.13.7 · Cited by 338
Emerging concepts of T cell metabolism as a target of immunotherapy
Chang, C.-H., & Pearce, E. L. (2016) · Nature Immunology · doi:10.1038/ni.3415 · Cited by 338
Tissue‐resident macrophages: then and now
Davies, L. C., & Taylor, P. R. (2015) · Immunology · doi:10.1111/imm.12451 · Cited by 334
Duluc, D., Corvaisier, M., Blanchard, S., Catala, L., Descamps, P., Gamelin, E., Ponsoda, S., Delneste, Y., Hebbar, M., & Jeannin, P. (2009) · International Journal of Cancer · doi:10.1002/ijc.24401 · Cited by 329
Pucci, F., Venneri, M. A., Biziato, D., Nonis, A., Moi, D., Sica, A., Di Serio, C., Naldini, L., & De Palma, M. (2009) · Blood · doi:10.1182/blood-2009-01-200931 · Cited by 328
Heterogeneity in the Differentiation and Function of CD8+ T Cells
Mittrücker, H.-W., Visekruna, A., & Huber, M. (2014) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-014-0293-y · Cited by 325
Self-citationCharacterization of an ovarian cancer activating factor in ascites from ovarian cancer patients.
Xu, Y., Gaudette, D. C., Boynton, J., Frankel, A., Fang, X. J., Sharma, A., Hurteau, J. A., Casey, G., Goodbody, A., & Mellors, A. (1995) · PubMed · Cited by 322
Revisiting Mouse Peritoneal Macrophages: Heterogeneity, Development, and Function
Cassado, A. D. A., D’Império Lima, M. R., & Bortoluci, K. R. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00225 · Cited by 315
Negus, R. P., Stamp, G. W., Relf, M. G., Burke, F., Malik, S. T., Bernasconi, S., Allavena, P., Sozzani, S., Mantovani, A., & Balkwill, F. R. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117933 · Cited by 315
Selective requirement for c-Rel during IL-12 P40 gene induction in macrophages
Sanjabi, S., Hoffmann, A., Liou, H.-C., Baltimore, D., & Smale, S. T. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.230436397 · Cited by 312
Hematogenous Metastasis of Ovarian Cancer: Rethinking Mode of Spread
Pradeep, S., Kim, S. W., Wu, S. Y., Nishimura, M., Chaluvally-Raghavan, P., Miyake, T., Pecot, C. V., Kim, S.-J., Choi, H. J., Bischoff, F. Z., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.05.002 · Cited by 311
Byrne, A. T., Ross, L. H., Holash, J., Nakanishi, M., Hu, L., Hofmann, J., Yancopoulos, G. D., & Jaffe, R. B. (2003) · PubMed · Cited by 310
Huang, R.-Y., Eppolito, C., Lele, S., Shrikant, P., Matsuzaki, J., & Odunsi, K. (2015) · Oncotarget · doi:10.18632/oncotarget.4751 · Cited by 308
Barbulescu, K., Becker, C., Schlaak, J., Schmitt, E., Büschenfelde, K. H. M. Z., & Neurath, M. F. (1998) · PubMed · Cited by 306
Mesothelial Cells Promote Early Ovarian Cancer Metastasis through Fibronectin Secretion
Kenny, H. A., Chiang, C.-Y., White, E. A., Schryver, E. M., Habis, M., Romero, I. L., Ladanyi, A., Penicka, C. V., George, J., Matlin, K., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci74778 · Cited by 303
Hu, X., Chakravarty, S. D., & Ivashkiv, L. B. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00707.x · Cited by 303
Ovarian Cancer Spheroids Use Myosin-Generated Force to Clear the Mesothelium
Iwanicki, M. P., Davidowitz, R. A., Ng, M. R., Besser, A., Muranen, T., Merritt, M., Danuser, G., Ince, T., & Brugge, J. S. (2011) · Cancer Discovery · doi:10.1158/2159-8274.cd-11-0010 · Cited by 303
T cell differentiation in chronic infection and cancer: functional adaptation or exhaustion?
Speiser, D. E., Utzschneider, D. T., Oberle, S. G., Münz, C., Romero, P., & Zehn, D. (2014) · Nature Reviews Immunology · doi:10.1038/nri3740 · Cited by 302
Systemic presence and tumor-growth promoting effect of ovarian carcinoma released exosomes
Keller, S., König, A.-K., Marmé, F., Runz, S., Wolterink, S., Koensgen, D., Mustea, A., Sehouli, J., & Altevogt, P. (2009) · Cancer Letters · doi:10.1016/j.canlet.2008.12.028 · Cited by 300
Targeting Nuclear Factor-Kappa B to Overcome Resistance to Chemotherapy
Godwin, P., Baird, A. M., Heavey, S., Barr, M. P., O’Byrne, K. J., & Gately, K. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00120 · Cited by 296
The origin and function of tumor-associated macrophages
Liu, Y., & Cao, X. (2015) · Cellular & Molecular Immunology · doi:10.1038/cmi.2014.83 · Cited by 291
Snijders, A., Hilkens, C. M., van der Pouw Kraan, T. C., Engel, M., Aarden, L. A., & Kapsenberg, M. L. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.3.1207 · Cited by 288
Xu, S., Tao, Z., Hai, B., Liang, H., Shi, Y., Wang, T., Song, W., Chen, Y., OuYang, J., Chen, J., et al. (2016) · Nature Communications · doi:10.1038/ncomms11406 · Cited by 287
Lysophospholipids activate ovarian and breast cancer cells
Xu, Y., Fang, X. J., Casey, G., & Mills, G. B. (1995) · Biochemical Journal · doi:10.1042/bj3090933 · Cited by 282
Mitra, A. K., Sawada, K., Tiwari, P., Mui, K., Gwin, K., & Lengyel, E. (2011) · Oncogene · doi:10.1038/onc.2010.532 · Cited by 274
Reinartz, S., Schumann, T., Finkernagel, F., Wortmann, A., Jansen, J. M., Meissner, W., Krause, M., Schwörer, A., Wagner, U., Müller‐Brüsselbach, S., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.28335 · Cited by 271
Self-citationCampbell, M. J., Tonlaar, N. Y., Garwood, E. R., Huo, D., Moore, D. H., Khramtsov, A. I., Au, A., Baehner, F., Chen, Y., Malaka, D. O., et al. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1154-y · Cited by 270
Burleson, K. M., Casey, R. C., Skubitz, K. M., Pambuccian, S. E., Oegema, T. R., & Skubitz, A. P. N. (2004) · Gynecologic Oncology · doi:10.1016/j.ygyno.2003.12.034 · Cited by 269
Expression of aldehyde dehydrogenase and CD133 defines ovarian cancer stem cells
Kryczek, I., Liu, S., Roh, M., Vatan, L., Szeliga, W., Wei, S., Banerjee, M., Mao, Y., Kotarski, J., Wicha, M. S., et al. (2012) · International Journal of Cancer · doi:10.1002/ijc.25967 · Cited by 266
Vascular permeability factor gene expression in normal and neoplastic human ovaries.
Olson, T. A., Mohanraj, D., Carson, L. F., & Ramakrishnan, S. (1994) · PubMed · Cited by 257
Proinvasive Properties of Ovarian Cancer Ascites-Derived Membrane Vesicles
Graves, L. E., Ariztia, E. V., Navari, J. R., Matzel, H. J., Stack, M. S., & Fishman, D. A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1800 · Cited by 256
Interactions of NF-κB with chromatin: the art of being at the right place at the right time
Natoli, G., Saccani, S., Bosisio, D., & Marazzi, I. (2005) · Nature Immunology · doi:10.1038/ni1196 · Cited by 250
Hu, Y.-L., Tee, M.-K., Goetzl, E. J., Auersperg, N., Mills, G. B., Ferrara, N., & Jaffe, R. B. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.10.762 · Cited by 246
Barbulescu, K., Becker, C., Schlaak, J. F., Schmitt, E., Meyer zum Büschenfelde, K.-H., & Neurath, M. F. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.8.3642 · Cited by 243
Interferon-gamma in the first-line therapy of ovarian cancer: a randomized phase III trial
Windbichler, G. H., Hausmaninger, H., Stummvoll, W., Graf, A. H., Kainz, C., Lahodny, J., Denison, U., Müller-Holzner, E., & Marth, C. (2000) · British Journal of Cancer · doi:10.1054/bjoc.1999.1053 · Cited by 241
Fishman, D. A., Stack, S., Ellerbroek, S. M., & Liu, Y. (2022) · PubMed · doi:10.7274/24738663 · Cited by 241
Latifi, A., Luwor, R. B., Bilandzic, M., Nazaretian, S., Stenvers, K., Pyman, J., Zhu, H., Thompson, E. W., Quinn, M. A., Findlay, J. K., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046858 · Cited by 240
Chemokines at the crossroads of tumor-fibroblast interactions that promote malignancy
Mishra, P., Banerjee, D., & Ben-Baruch, A. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.0310182 · Cited by 239
Autotaxin and LPA receptor signaling in cancer
Houben, A. J. S., & Moolenaar, W. H. (2011) · Cancer and Metastasis Reviews · doi:10.1007/s10555-011-9319-7 · Cited by 233
Xiao, Y.-J., Schwartz, B., Washington, M., Kennedy, A., Webster, K., Belinson, J., & Xu, Y. (2001) · Analytical Biochemistry · doi:10.1006/abio.2001.5000 · Cited by 232
Masoumi Moghaddam, S., Amini, A., Morris, D. L., & Pourgholami, M. H. (2012) · Cancer and Metastasis Reviews · doi:10.1007/s10555-011-9337-5 · Cited by 228
Targeting regulatory T cells in tumors
Liu, C., Workman, C. J., & Vignali, D. A. A. (2016) · The FEBS Journal · doi:10.1111/febs.13656 · Cited by 228
CD44 and β1 Integrin Mediate Ovarian Carcinoma Cell Adhesion to Peritoneal Mesothelial Cells
Lessan, K., Aguiar, D. J., Oegema, T., Siebenson, L., & Skubitz, A. P. N. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65406-5 · Cited by 226
Arachidonic acid and free fatty acids as second messengers and the role of protein kinase C
Khan, W. A., Blobe, G. C., & Hannun, Y. A. (1995) · Cellular Signalling · doi:10.1016/0898-6568(94)00089-t · Cited by 225
IRF4 at the crossroads of effector T‐cell fate decision
Huber, M., & Lohoff, M. (2014) · European Journal of Immunology · doi:10.1002/eji.201344279 · Cited by 221
Self-citationRen, J., Xiao, Y.-J., Singh, L. S., Zhao, X., Zhao, Z., Feng, L., Rose, T. M., Prestwich, G. D., & Xu, Y. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-1292 · Cited by 220
Kajiyama, H., Shibata, K., Terauchi, M., Ino, K., Nawa, A., & Kikkawa, F. (2008) · International Journal of Cancer · doi:10.1002/ijc.23083 · Cited by 220
A Dynamic Inflammatory Cytokine Network in the Human Ovarian Cancer Microenvironment
Kulbe, H., Chakravarty, P., Leinster, D. A., Charles, K. A., Kwong, J., Thompson, R. G., Coward, J. I., Schioppa, T., Robinson, S. C., Gallagher, W. M., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2178 · Cited by 220
Binding of ovarian cancer cells to peritoneal mesothelium in vitro is partly mediated by CD44H.
Cannistra, S., Kansas, G. S., Niloff, J. M., DeFranzo, B., Kim, Y. S., & Ottensmeier, C. H. H. (1993) · PubMed · Cited by 211
Preston, C. C., Maurer, M. J., Oberg, A. L., Visscher, D. W., Kalli, K. R., Hartmann, L. C., Goode, E. L., & Knutson, K. L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080063 · Cited by 208
Gobbo, J., Marcion, G., Cordonnier, M., Dias, A. M. M., Pernet, N., Hammann, A., Richaud, S., Mjahed, H., Isambert, N., Clausse, V., et al. (2016) · Journal of the National Cancer Institute · doi:10.1093/jnci/djv330 · Cited by 205
Giuntoli, R. L., Webb, T. J., Zoso, A., Rogers, O. C., Diaz-Montes, T. P., Bristow, R. E., & Oelke, M. (2009) · PubMed · Cited by 199
Prognostic significance of interleukin 6 serum levels in patients with ovarian cancer
Scambia, G., Testa, U., Benedetti Panici, P., Foti, E., Martucci, R., Gadducci, A., Perillo, A., Facchini, V, Peschle, C., & Mancuso, S. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.71 · Cited by 198
Cleavage of L1 in Exosomes and Apoptotic Membrane Vesicles Released from Ovarian Carcinoma Cells
Gutwein, P., Stoeck, A., Riedle, S., Gast, D., Runz, S., Condon, T. P., Marmé, A., Phong, M.-C., Linderkamp, O., Skorokhod, A., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1688 · Cited by 198
Yang, Y., Zou, J.-P., Mu, J., Wijesuriya, R., Ono, S., Walunas, T. L., Bluestone, J. A., Fujiwara, H., & Hamaoka, T. (1997) · PubMed · Cited by 197
Risk Prediction for Late-Stage Ovarian Cancer by Meta-analysis of 1525 Patient Samples
Riester, M., Wei, W., Waldron, L., Culhane, A. C., Trippa, L., Oliva, E., Kim, S.-H., Michor, F., Huttenhower, C., Parmigiani, G., et al. (2014) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dju048 · Cited by 195
IL-6 Trans-Signaling in Formation and Progression of Malignant Ascites in Ovarian Cancer
Lo, C.-W., Chen, M.-W., Hsiao, M., Wang, S., Chen, C.-A., Hsiao, S.-M., Chang, J.-S., Lai, T.-C., Rose-John, S., Kuo, M.-L., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-1496 · Cited by 193
Skinner, H. D., Zheng, J. Z., Fang, J., Agani, F., & Jiang, B.-H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404097200 · Cited by 192
Mechanisms for Lysophosphatidic Acid-induced Cytokine Production in Ovarian Cancer Cells
Fang, X., Yu, S., Bast, R. C., Liu, S., Xu, H.-J., Hu, S.-X., LaPushin, R., Claret, F. X., Aggarwal, B. B., Lu, Y., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m306662200 · Cited by 192
Prognostic significance of IL-6 and IL-8 ascites levels in ovarian cancer patients
Lane, D., Matte, I., Rancourt, C., & Piché, A. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-210 · Cited by 190
Profiling of cytokines in human epithelial ovarian cancer ascites.
Matte, I., Lane, D. A., Laplante, C., Rancourt, C., & Piché, A. (2012) · Europe PMC (PubMed Central) · Cited by 188
Thibault, B., Castells, M., Delord, J.-P., & Couderc, B. (2014) · Cancer and Metastasis Reviews · doi:10.1007/s10555-013-9456-2 · Cited by 184
Colombo, N., Peiretti, M., Parma, G., Lapresa, M., Mancari, R., Carinelli, S., Sessa, C., & Castiglione, M. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq244 · Cited by 184
CD44+/CD24− ovarian cancer cells demonstrate cancer stem cell properties and correlate to survival
Meng, E., Long, B., Sullivan, P., McClellan, S., Finan, M. A., Reed, E., Shevde, L., & Rocconi, R. P. (2012) · Clinical & Experimental Metastasis · doi:10.1007/s10585-012-9482-4 · Cited by 180
Exosomes in the ascites of ovarian cancer patients: origin and effects on anti-tumor immunity
Keng (2011) · Oncology Reports · doi:10.3892/or.2010.1119 · Cited by 180
Clinical relevance of circulating cell-free microRNAs in ovarian cancer
Nakamura, K., Sawada, K., Yoshimura, A., Kinose, Y., Nakatsuka, E., & Kimura, T. (2016) · Molecular Cancer · doi:10.1186/s12943-016-0536-0 · Cited by 180
Krockenberger, M., Dombrowski, Y., Weidler, C., Ossadnik, M., Hönig, A., Häusler, S., Voigt, H., Becker, J. C., Leng, L., Steinle, A., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.11.7338 · Cited by 179
B7-H6-mediated downregulation of NKp30 in NK cells contributes to ovarian carcinoma immune escape
Pesce, S., Tabellini, G., Cantoni, C., Patrizi, O., Coltrini, D., Rampinelli, F., Matta, J., Vivier, E., Moretta, A., Parolini, S., et al. (2015) · OncoImmunology · doi:10.1080/2162402x.2014.1001224 · Cited by 178
Malignant effusions contain lysophosphatidic acid (LPA)-like activity
Westermann, A. M., Havik, E., Postma, F. R., Beijnen, J. H., Dalesio, O., Moolenaar, W. H., & Rodenhuis, S. (1998) · Annals of Oncology · doi:10.1023/a:1008217129273 · Cited by 177
Marchini, S., Fruscio, R., Clivio, L., Beltrame, L., Porcu, L., Nerini, I. F., Cavalieri, D., Chiorino, G., Cattoretti, G., Mangioni, C., et al. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2012.06.026 · Cited by 176
Takaishi, K., Komohara, Y., Tashiro, H., Ohtake, H., Nakagawa, T., Katabuchi, H., & Takeya, M. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01652.x · Cited by 170
β1-Integrins Partly Mediate Binding of Ovarian Cancer Cells to Peritoneal Mesothelium in Vitro
Strobel, T., & Cannistra, S. A. (1999) · Gynecologic Oncology · doi:10.1006/gyno.1999.5388 · Cited by 168
Ziogas, A. C., Gavalas, N. G., Tsiatas, M., Tsitsilonis, O., Politi, E., Terpos, E., Rodolakis, A., Vlahos, G., Thomakos, N., Haidopoulos, D., et al. (2012) · International Journal of Cancer · doi:10.1002/ijc.26094 · Cited by 168
Expression and activity of MMPS and their regulators in ovarian cancer
Naylor, M. S., Stamp, G. W., Davies, B. D., & Balkwill, F. R. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910580110 · Cited by 168
Wong, J. L., Berk, E., Edwards, R. P., & Kaliński, P. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4366 · Cited by 163
The role of LPA and YAP signaling in long-term migration of human ovarian cancer cells
Cai, H., & Xu, Y. (2013) · Cell Communication and Signaling · doi:10.1186/1478-811x-11-31 · Cited by 161
Mould, A. P., Askari, J. A., Aota, S.-I., Yamada, K. M., Irie, A., Takada, Y., Mardon, H. J., & Humphries, M. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.28.17283 · Cited by 159
Pujade-Lauraine, E., Guastalla, J. P., Colombo, N., Devillier, P., François, E., Fumoleau, P., Monnier, A., Nooy, M., Mignot, L., Bugat, R., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.2.343 · Cited by 158
Consequences of the crosstalk between monocytes/macrophages and natural killer cells
Michel, T., Hentges, F., & Zimmer, J. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00403 · Cited by 156
Kim, K.-S., Sengupta, S., Berk, M. P., Kwak, Y., Escobar, P. F., Belinson, J. L., Mok, S. C., & Xu, Y. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4381 · Cited by 156
Ridnour, L. A., Cheng, R. Y. S., Switzer, C., Heinecke, J. L., Ambs, S., Glynn, S. A., Young, H. A., Trinchieri, G., & Wink, D. A. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0408 · Cited by 152
Huynh, M.-L. N., Malcolm, K. C., Kotaru, C., Tilstra, J. A., Westcott, J. Y., Fadok, V. A., & Wenzel, S. E. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200501-035oc · Cited by 151
Epigenetic and transcriptional control of Foxp3+ regulatory T cells
Huehn, J., & Beyer, M. (2015) · Seminars in Immunology · doi:10.1016/j.smim.2015.02.002 · Cited by 149
Ovarian cancer stem cells: Working towards the root of stemness
Foster, R., Buckanovich, R. J., & Rueda, B. R. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.10.023 · Cited by 148
Immunity and Immune Suppression in Human Ovarian Cancer
Preston, C. C., Goode, E. L., Hartmann, L. C., Kalli, K. R., & Knutson, K. L. (2011) · Immunotherapy · doi:10.2217/imt.11.20 · Cited by 144
Kassim, S. K., El-Salahy, E. M., Fayed, S. T., Helal, S. A., Helal, T., Azzam, E. E.-D., & Khalifa, A. (2004) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2004.01.014 · Cited by 144
Mills, G. B., May, C., Hill, M., Campbell, S., Shaw, P. H., & Marks, A. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114784 · Cited by 141
Epithelial ovarian cancer cells secrete functional Fas ligand.
Abrahams, V. M., Chavez, S. L., Kamsteeg, M., Hanczaruk, B., Schwartz, P. E., Rutherford, T., & Mor, G. (2003) · PubMed · Cited by 139
Interactions of human ovarian tumor cells with human mesothelial cells grown on extracellular matrix
Niedbala, M. J., Crickard, K., & Bernacki, R. J. (1985) · Experimental Cell Research · doi:10.1016/0014-4827(85)90197-1 · Cited by 137
Mesenchymal gene program–expressing ovarian cancer spheroids exhibit enhanced mesothelial clearance
Davidowitz, R. A., Selfors, L. M., Iwanicki, M., Elias, K. M., Karst, A. M., Piao, H., Ince, T. A., Drage, M. G., Dering, J., Konecny, G. E., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci69815 · Cited by 137
Ubiquitous Release of Exosomal Tumor Suppressor miR-6126 from Ovarian Cancer Cells
Kanlikilicer, P., Rashed, M. H., Bayraktar, R., Mitra, R., Ivan, C., Aslan, B., Zhang, X., Filant, J., da Silva, A. M., Rodriguez‐Aguayo, C., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0714 · Cited by 136
Hartenbach, E. M., Olson, T. A., Goswitz, J. J., Mohanraj, D., Twiggs, L. B., Carson, L. F., & Ramakrishnan, S. (1997) · Cancer Letters · doi:10.1016/s0304-3835(97)00350-9 · Cited by 133
A c-Rel subdomain responsible for enhanced DNA-binding affinity and selective gene activationPreprint
Sanjabi, S., Williams, K. J., Saccani, S., Zhou, L., Hoffmann, A. A., Ghosh, G., Gerondakis, S., Natoli, G., & Smale, S. T. (2005) · Genes & Development · doi:10.1101/gad.1329805 · Cited by 132
IL-10 Immunomodulation of Myeloid Cells Regulates a Murine Model of Ovarian Cancer
Hart, K. M., Byrne, K. T., Molloy, M. J., Usherwood, E., & Berwin, B. L. (2011) · Frontiers in Immunology · doi:10.3389/fimmu.2011.00029 · Cited by 124
Ströbel, T., Swanson, L., & Cannistra, S. A. (1997) · PubMed · Cited by 123
Role of the autotaxin–lysophosphatidate axis in cancer resistance to chemotherapy and radiotherapy
Brindley, D. N., Lin, F., & Tigyi, G. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2012.08.015 · Cited by 123
Next-Generation Sequencing of Tubal Intraepithelial Carcinomas
McDaniel, A. S., Stall, J. N., Hovelson, D. H., Cani, A. K., Liu, C., Tomlins, S. A., & Cho, K. R. (2015) · JAMA Oncology · doi:10.1001/jamaoncol.2015.1618 · Cited by 118
Kelleher, R. J., Balu‐Iyer, S. V., Loyall, J. L., Sacca, A. J., Shenoy, G. N., Peng, P., Iyer, V., Fathallah, A. M., Berenson, C. S., Wallace, P. K., et al. (2015) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-15-0086 · Cited by 118
The origin and function of tumor-associated macrophages
Yang, Y. Y. Y., Liu, Xuetao, & Cao (2015) · 中国免疫学杂志:英文版 · Cited by 118
Alberti, C., Pinciroli, P., Valeri, B., Ferri, R., Ditto, A., Umezawa, K., Sensi, M., Canevari, S., & Tomassetti, A. (2011) · Oncogene · doi:10.1038/onc.2011.572 · Cited by 115
Cited by
The Role of Tumor-Associated Macrophages in the Progression and Chemoresistance of Ovarian Cancer
Nowak, M., & Klink, M. (2020) · Cells · doi:10.3390/cells9051299 · Cited by 287
Motohara, T., Masuda, K., Morotti, M., Zheng, Y., El-Sahhar, S., Chong, K. Y., Wietek, N., Alsaadi, A., Carrami, E. M., Hu, Z., et al. (2019) · Oncogene · doi:10.1038/s41388-018-0637-x · Cited by 218
Finkernagel, F., Reinartz, S., Schuldner, M., Malz, A., Jansen, J. M., Wagner, U., Worzfeld, T., Graumann, J., von Strandmann, E. P., & Müller, R. (2019) · Theranostics · doi:10.7150/thno.37549 · Cited by 55
Self-citation
Metadata
- Authors
- Worzfeld, T., Pogge von Strandmann, E., Huber, M., Adhikary, T., Wagner, U., Reinartz, S., & Müller, R.
- Venue
- Frontiers in Oncology
- Publisher
- Frontiers Media SA
- Published
- 2017-02-22
- Volume
- 7
- Pages
- 24-24
- ISSN
- 2234-943X (ISSN-L)
- OpenAlex
- W2589658059
- Cited by
- 288
- References
- 262
- FWCI
- 26.22
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.